Table 2.
Clinical Symptoms | N = 321, n (%) |
---|---|
No | 111 (34.6) |
Yes | 210 (65.4) |
Cough | 129 (40.2) |
Fever | 42 (13.1) |
Shortness of breath | 23 (7.2) |
Chest pain | 21 (6.5) |
Hemoptysis | 10 (3.1) |
Dizziness/headache | 10 (3.1) |
Decreased appetite/weight loss | 8 (2.5) |
Fatigue | 7 (2.2) |
Chillness | 6 (1.9) |
Altered consciousness/neurological deficit | 4 (1.2) |
Extent of disease | N = 321, n (%) |
Extrapulmonary involvement | |
No | 299 (93.1) |
Yes | 22 (6.9) |
Central nervous system (CNS) | 18 (5.6) |
Fungemia | 8 (2.5) |
Others * | 4 (1.2) |
Findings on chest computed tomography | N = 305, n (%) |
Extent of pulmonary cryptococcosis | |
Single lobe | 185 (60.7) |
Multiple lobes # | 120 (39.3) # |
Radiological presentations | |
Multiple nodules/masses with or without cavitation,$ | 161 (52.8) |
Consolidation | 52 (17.0) |
Solitary nodule/mass with or without cavitation $ | 48 (15.7) |
Ground glass opacity | 3 (1.0) |
Mixed pattern $,& | 41 (13.4) |
Associated findings | |
Pleural effusion | 11 (3.6) |
Lymphadenopathy | 5 (1.6) |
* Includes 1 with urinary tract infection, 1 with paraspinal abscess, and 2 with neck lymph node infection. # Includes 88 patients with involvement of both lungs. $ Among patients with nodule(s) or mass(es), a total of 37 patients with cavitation. & Most common are consolidation mixed with nodule(s)/mass(es) (n = 29).